Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
09/1998
09/03/1998WO1998038167A1 Heteroaryl-hexanoic acid amide derivatives, their preparation and their use as selective inhibitors of mip-1-alpha binding to its ccr1 receptor
09/03/1998WO1998038163A1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
09/03/1998WO1998037914A1 Remedies for hepatitis
09/03/1998WO1998037912A1 A new composite vaccine which contains antigen, antibody and recombinant dna and its preparing method
09/03/1998WO1998037901A1 Self-regulated apoptosis of inflammatory cells by gene therapy
09/03/1998WO1998037899A1 Liver protection or treatment agents comprising asiatic acid derivatives as the active component
09/03/1998WO1998037892A1 Tamoxifen as a therapy to reduce irinotecan hydrochloride-induced diarrhea
09/03/1998WO1998037889A1 Use of descarboethoxyloratadine for the manufacture of a medicament for the treatment of urinary incontinence, motion sickness and vertigo
09/03/1998WO1998037877A1 N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
09/03/1998CA2282656A1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
09/03/1998CA2282655A1 N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
09/03/1998CA2282396A1 Use of descarboethoxyloratadine for the manufacture of a medicament for the treatment of urinary incontinence, motion sickness and vertigo
09/03/1998CA2281664A1 Reverse hydroxamate derivatives as metalloprotease inhibitors
09/03/1998CA2281567A1 Self-regulated apoptosis of inflammatory cells by gene therapy
09/03/1998CA2280855A1 Tamoxifen as a therapy to reduce irinotecan hydrochloride-induced diarrhea
09/03/1998CA2252629A1 Remedies for hepatitis
09/02/1998EP0861898A1 Rat Cathepsin K polynucleotide & polypeptide sequence
09/02/1998EP0861897A2 Recombinant bile salt activated lipases
09/02/1998EP0861850A1 Tumor necrosis related receptor, TR4
09/02/1998EP0861836A1 Sulfonamido substituted condensed, seven-membered ring compounds with potassium channel blocking activity
09/02/1998EP0861252A1 NAPHTHAMIDE DERIVATIVES OF 3 $g(b)-AMINO AZABICYCLO OCTANE OR NONANE AS NEUROLEPTIC AGENTS
09/02/1998EP0861238A1 Hexahydro-5-imino-1,4-heteroazepine derivatives as inhibitors of nitric oxide synthases
09/02/1998EP0861235A1 Substituted benzylaminopiperidine compounds
09/02/1998EP0861083A1 Microcellulose-based preparations
09/02/1998EP0861074A1 Non-ionic surfactant vesicles as therapeutic agent
09/02/1998EP0766696B1 Thiazolidine derivatives, their preparation and drugs containing same
09/02/1998CN1192237A 人MP52 Arg蛋白 People MP52 Arg protein
09/02/1998CN1192234A Replacement therapy for dental caries
09/02/1998CN1192219A Reversible cysteine protease inhibitors
09/02/1998CN1192213A (R)-5-bromo-N-(1-ethyl-4-methylhexahy dro-1H-1,4-diazepin-6-YL)-2-methoxy-6-methylamino-3-pyridine-carboxamide
09/02/1998CN1192151A Micro-encapsulated lactobacilli for medical applications
09/02/1998CN1192144A 1H-4(5)-substituted imidazole derivatives
09/02/1998CN1191734A Externally used medicine bag for curing peptic ulcer and acute and chronic gastritis and its making process
09/01/1998US5801040 Nucleic acid coding for the human testicular angiotensin converting enzyme (ACE ) and its uses, especially for the in vitro screening for this enzyme in the organism
09/01/1998CA2166903C 3-amidopyrazole derivatives, process for preparing these and pharmaceutical compositions containing them
08/1998
08/27/1998WO1998037094A2 Secreted proteins and polynucleotides encoding them
08/27/1998WO1998037080A1 Compounds for inhibition of gastric acid secretion
08/27/1998WO1998037061A1 Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases
08/27/1998WO1998036747A1 Pharmaceutical composition
08/27/1998WO1998036745A2 Use of polyunsaturated fatty acids for reducing the incidence of necrotizing enterocolitis
08/27/1998WO1998036733A2 Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker
08/27/1998WO1998024782A3 Substituted pyrimidine compounds and their use
08/27/1998CA2281059A1 Secreted proteins and polynucleotides encoding them
08/27/1998CA2280008A1 Compounds for inhibition of gastric acid secretion
08/26/1998EP0860440A1 Sulfonamido substituted chromane derivatives with potassium channel blocking activity
08/26/1998EP0859784A1 Thio-substituted peptides as inhibitors for metalloproteinases and tnf liberation
08/26/1998EP0859779A1 Interleukin converting enzyme and apoptosis
08/26/1998EP0859771A1 Substituted pyridyl pyrroles, compositions containing such compounds and methods of use
08/26/1998EP0859762A1 Cytokine production inhibitors, formulations thereof and their use in medicine, and methods for their identification
08/26/1998EP0859622A1 Extracts of shark cartilage
08/26/1998EP0739336B1 Gem-disubstituted azacyclic tachykinin antagonists
08/26/1998EP0563093B1 A composition used as a therapeutic agent against chronic viral hepatic diseases
08/26/1998CN1191533A 1-benzoyl-2-(indolyl-3-alkyl)-piperazine derivs. as neurokinin receptor antagonists
08/26/1998CN1191132A Medicine for promoting digestion function of stomach and intestine
08/26/1998CN1191117A 'Ruwei' powder medicine for gastroenteric diseases
08/26/1998CA2230349A1 Sulfonamide-substituted fused 7-membered ring compounds, processes for their preparation, their use as a medicament or diagnostic, and pharmaceutical preparations comprising them
08/26/1998CA2225174A1 Rat cathepsin k polynucleotide & polypeptide sequence
08/25/1998US5798373 Tri-substituted phenyl derivatives useful as PDE IV inhibitors
08/25/1998US5798367 Indazolecarboxamides
08/25/1998US5798363 Use for tachykinin antagonists to treat emesis
08/25/1998US5798353 Treating eating disorder, obesity, diabetes, psychological disorder, sexual disorder, psychosis, memory disorder
08/25/1998US5798336 Antimicrobial peptides
08/25/1998US5797906 Retrograde tissue splitter and method
08/25/1998CA2122478C Unit dose form of bismuth subsalicylate
08/25/1998CA2086247C Food and pharmaceutical compositions containing short chain monounsaturated fatty acids and methods of using
08/20/1998WO1998036075A1 Variants of vascular endothelial cell growth factor having altered pharmacological properties, and related aspects thereof
08/20/1998WO1998035979A1 Oligomers which inhibit expression of collagen genes
08/20/1998WO1998035967A2 Biazacyclic crf antagonists
08/20/1998WO1998035685A1 Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy for treating hepatitis virus infections
08/20/1998CA2281525A1 Biazacyclic crf antagonists
08/20/1998CA2281086A1 Oligomers which inhibit expression of collagen genes
08/20/1998CA2280209A1 Variants of vascular endothelial cell growth factor having altered pharmacological properties, and related aspects thereof
08/20/1998CA2229947A1 Sulfonamide-substituted chromans, processes for their preparation, their use as medicament or diagnostic aid, and medicament comprising them
08/19/1998EP0858804A1 Use of rifaximin in the treatment of the diarrhoea from cryptosporidiosis
08/19/1998EP0858504A1 Diagnostics and treatments of periodontal disease
08/19/1998EP0858450A1 Quinolone compounds for the treatment of disorders caused by helicobacter pylori
08/19/1998EP0858444A1 Cyclopentyl tachykinin receptor antagonists
08/19/1998EP0858337A2 A pharmaceutical composition for the treatment of autoimmune diseases
08/19/1998EP0858326A1 Non-aqueous colonic purgative formulations
08/19/1998EP0643068B1 Erythromycin derivative
08/19/1998CN1190970A Resolution of 1-azabicyclo £2.2.2| octan-3-amine, 2-(diphenylmethyl)-N-££2-methoxy-5-(1-methylethyl) phenyl| methyl|
08/19/1998CN1190896A Stabilized pharmaceutical formulation comprising a growth hormone and a peptide comprising at least, one basic amino acid residue and at least one acid amino acid residue
08/19/1998CN1190895A Use of ribavirin and interferon alpha for the treatment of hepatitis C
08/19/1998CN1190892A Pharmaceutical compositions, based on etheric oils obtained from plants for use in the human and veterinary medical field
08/19/1998CN1190595A Traditional Chinese powder medicine Kedusan and preparation method thereof
08/19/1998CN1190588A Umbilicus-dressing powder medicine for antidiarrhea
08/19/1998CN1190585A Herbs prescription for hepatitis
08/18/1998US5795905 CRF receptor antagonists and methods relating thereto
08/18/1998US5795888 Analgesics, antiinflammatory agents, antidiabetic agents
08/18/1998US5795887 Method of inducing cholecystokinin agonist activity using 1,4- Benzodiazepine compounds
08/18/1998US5795861 Methods for regulating gastrointestinal motility
08/18/1998US5795858 Treatment or prevention of Crohn's disease and/or ulcerative colitis
08/18/1998US5795778 Using enzymatic rna compound
08/18/1998US5795574 Use of an extract from a non-photosynthetic filamentous bacterium and composition containing it
08/18/1998CA2090340C Method of extracting sennosides a, b and a1
08/18/1998CA2085008C Calcium citrate malate composition
08/13/1998WO1998035043A1 Human sdf-5 protein and compositions
08/13/1998WO1998034949A2 Monocyclic compounds with four bifunctional residues having nk-2 antagonist action
08/13/1998WO1998034929A1 Il-8 receptor antagonists
08/13/1998WO1998034919A1 2-amino-6-(2-substituted-4-phenoxy)-substituted-pyridines
1 ... 1129 1130 1131 1132 1133 1134 1135 1136 1137 1138 1139 1140 1141 1142 1143 1144 1145 1146 1147 1148 1149 ... 1258